Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma

S. Verhoeff, S. C. van Es, E. Boon, E. van Helden, L. Angus, S. G. Elias, S. F. Oosting, E. H. Aarntzen, A. H. Brouwers, T. C. Kwee, S. Heskamp, O. S. Hoekstra, H. Verheul, G. J. C. Zwezerijnen, C. Menke-van der Houven van Oordt, A. A. M. van der Veldt, E. G. E. de Vries, O. C. Boerman, W. T. A. van der Graaf, W. J. G. OyenC. M. L. van Herpen

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S67
Number of pages1
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Issue numberSUPPL 1
Publication statusPublished - Oct-2019
Event32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) - Barcelona, Spain
Duration: 12-Oct-201916-Oct-2019

Cite this